Multi-center Application of Quantitative FIT Technology in Colorectal Cancer Screening

Summary

In order to control the incidence of colorectal cancer, improve the level of early diagnosis and early warning the occurrence of colorectal cancer, it is very necessary for us to explore the threshold value of FIT positive judgment in line with the Chinese population, and further contribute to the establishment of a colorectal cancer screening pathway suitable for Chinese healthy population

Conditions

• Colorectal Cancer Screening Fecal Immunochemical Test

Interventions

DEVICE

Quantitative Fecal Immunochemical Test (qFIT)

The study only included quantitative FIT examination in the general physical examination population over 30 years old.

Sponsors & Collaborators

• The First Affiliated Hospital of Anhui Medical University

  collaborator OTHER

• The Second Hospital of Anhui Medical University

  collaborator OTHER

• The First Hospital of Jilin University

  collaborator OTHER

• Sino-Japanese Friendship Hospital of Jilin University

  collaborator UNKNOWN

• First Hospital of China Medical University

  collaborator OTHER

• The First Affiliated Hospital of Dalian Medical University

  collaborator OTHER

• The Second Affiliated Hospital of Dalian Medical University

  collaborator OTHER

• The Second Hospital of Hebei Medical University

  collaborator OTHER

• The First Hospital of Hebei Medical University

  collaborator OTHER

• Jiangsu Provincial People's Hospital

  collaborator OTHER

• The Second Hospital of Nanjing Medical University

  collaborator OTHER

• Jiangxi Provincial People's Hopital

  collaborator OTHER

• Second Affiliated Hospital of Nanchang University

  collaborator OTHER

• First Affiliated Hospital of Harbin Medical University

  collaborator OTHER

• Peking Union Medical College Hospital

  collaborator OTHER

• Shenzhen People's Hospital

  collaborator OTHER

• Guangdong Provincial People's Hospital

  collaborator OTHER

• Tongji Hospital

  collaborator OTHER

• First Affiliated Hospital of Suzhou Medical College

  collaborator OTHER

• Chinese PLA General Hospital

  collaborator OTHER

• Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

  collaborator OTHER

• The First Affiliated Hospital of Inner Mongolia Medical College

  collaborator UNKNOWN

• Bethune International Peace Hospital

  collaborator OTHER

• Xinqiao Hospital of Chongqing

  collaborator OTHER

• Renmin Hospital of Wuhan University

  collaborator OTHER

• The Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine

  collaborator OTHER

• Second Affiliated Hospital, School of Medicine, Zhejiang University

  lead OTHER

Eligibility

Min Age

30 Years

Sex

ALL

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2019-01-06

Primary Completion

2021-12-31

Completion

2022-12-31

FDA Device

Yes

Countries

• China

Study Locations